Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/221584


Analgesics in Spain


Description: Our Analgesics in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?
- Get a detailed picture of the analgesics industry
- Pinpoint growth sectors and trends and identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop

EXECUTIVE SUMMARY

Demographics Shaping Sales
Two main demographic factors are crucial in explaining the development of OTC sales in Spain in the latter part of the review period. The first is the birth rate, which recovered in 2005 and 2006, and with it growth in childspecific products. The second is the ageing of the Spanish population, which is contributing positively to sales of medicated skin care and digestive remedies.

Low Incidence of Flu Shapes Sales for the Second Year in A Row
Much in line with 2005, value sales of OTC products were limited by the low influence of the flu in 2006. This, along with the mild temperatures registered in the winter of 2006, limited sales of cough and cold remedies and analgesics, and had a significant impact on the wider Spanish OTC market.

Fragmentation Defines Spanish OTC Market
With over 100 companies active in OTC healthcare in Spain, fragmentation largely characterises the market, as a result of a high degree of specialisation within sectors. According to industry sources, most pharmaceutical companies specialise in one or two subsectors, which leads to a substantial number of players being in the market.

Internet Arrived
Although in 2006, some 90% of OTC value sales were still made through pharmacies, Internet selling has arrived, with new legislation regarding the distribution of medicines. Whilst the law forbids the selling of prescription medicines via the Internet or other distant-selling mechanisms, the sale of non-reimbursed nonprescription medicines is permitted.

New Legal Framework
In June 2006, the Ministry of Health passed new legislation regarding medicines, which will come into force in 2007. This new legislation changes the legal framework for OTC healthcare in Spain, although non-reimbursed non-prescription medicines are not greatly affected.
Other new laws are expected to be passed in the near future. New legislation regulating food supplements, antialcoholism legislation and further legislation to enhance public health are set to benefit the performance of OTC products over the forecast period.


Contents: OTC HEALTHCARE IN SPAIN
Executive Summary
Demographics Shaping Sales
Low Incidence of Flu Shapes Sales for the Second Year in A Row
Fragmentation Defines Spanish OTC Market
Internet Arrived
New Legal Framework
Key Trends and Developments
Spanish Lifestyles
Demographics Shaping Sales
Too Many Laws
Climate Change
Health Drives Sales
Market Indicators
Table 1 Life Expectancy at Birth 2001-2006
Market Data
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Waste
Distribution
De-listing Or De-reimbursement
Vitamins and Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
Definitions
Sources
Summary 1 Research Sources

LOCAL COMPANY PROFILES - SPAIN
Almirall Prodesfarma SA
Strategic Direction
Key Facts
Summary 2 Almirall Prodesfarma SA: Key Facts
Summary 3 Almirall Prodesfarma SA: Operational Indicators
Company Background
Production
Competitive Positioning
Boehringer Ingelheim España SA
Strategic Direction
Key Facts
Summary 4 Boehringer Ingelheim España SA: Key Facts
Summary 5 Boehringer Ingelheim España SA: Operational Indicators
Company Background
Production
Competitive Positioning
Boots Healthcare Iberia
Strategic Direction
Key Facts
Summary 6 Boots Healthcare Iberia: Key Facts
Company Background
Production
Competitive Positioning
GlaxoSmithKline SA
Strategic Direction
Key Facts
Summary 7 GlaxoSmithKline SA: Key Facts
Summary 8 GlaxoSmithKline SA: Operational Indicators
Company Background
Production
Competitive Positioning
Johnson & Johnson SA
Strategic Direction
Key Facts
Summary 9 Johnson & Johnson SA: Key Facts
Summary 10 Johnson & Johnson SA: Operational Indicators
Company Background
Production
Competitive Positioning
Merck Farma Y Química SA
Strategic Direction
Key Facts
Summary 11 Merck Farma y Química SA: Key Facts
Summary 12 Merck KGaA: Operational Indicators
Company Background
Competitive Positioning
Novartis Consumer Health SA
Strategic Direction
Key Facts
Summary 13 Novartis Consumer Health SA: Key Facts
Summary 14 Novartis Consumer Health SA: Operational Indicators
Company Background
Production
Competitive Positioning
Pfizer SA
Strategic Direction
Key Facts
Summary 15 Pfizer SA: Key Facts
Summary 16 Pfizer SA: Operational Indicators
Company Background
Competitive Positioning
Química Farmacéutica Bayer SA
Strategic Direction
Key Facts
Summary 17 Química Farmacéutica Bayer SA: Key Facts
Summary 18 Química Farmacéutica Bayer SA: Operational Indicators
Company Background
Production
Competitive Positioning
Uriach-aquilea OTC Sl
Strategic Direction
Key Facts
Summary 19 Uriach-Aquilea OTC SL: Key Facts
Summary 20 Uriach-Aquilea OTC SL: Operational Indicators
Company Background
Competitive Positioning

ANALGESICS IN SPAIN
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by Subsector: Value 2001-2006
Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Topical Analgesics 2001/2006
Table 15 Analgesics Company Shares by Retail Value 2002-2006
Table 16 Analgesics Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011


Companies Mentioned Almirall Prodesfarma SA Boehringer Ingelheim España SA Pfizer SA Novartis Consumer Health SA Merck Farma y Química SA Boots Healthcare Iberia Johnson & Johnson SA GlaxoSmithKline SA Uriach-Aquilea OTC SL Química Farmacéutica Bayer SA


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/221584

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 08/09/2008 04:01:06
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Analgesics in Spain
Web Address:
http://www.researchandmarkets.com/reports/221584
Office Code:
OCHHIJRQSVR

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €675.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 08/09/2008 04:01:06

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World